EUVIMEDEUVIMED entdecken
Crossref

Patch Testing in the Age of Artificial Intelligence (AI): Opportunities and Risks

Shaymaa Al-tharwane, Mohammed S Al Abadie *

Dermatology and Dermatitis · 26.03.2026 · 13 (01) · 01-07

DOI: 10.31579/2578-8949/204 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dermatology and Dermatitis, online erschienen am 26.03.2026. Verfasst von Shaymaa Al-tharwane und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patch testing is constrained by subjectivity, interobserver variability, and structural barriers to access. Artificial intelligence (AI), particularly machine learning and deep learning, offers a potential solution to standardise interpretation and expand diagnostic capacity. However, current gaps in validation and standardisation limit these systems to exploratory roles rather than deployable clinical instruments.

Aim

This review aims to critically evaluate the application of AI to patch testing in contact dermatitis, focusing on diagnostic performance, methodological strengths, and current limitations regarding clinical integration. Materials and Methods: Following PRISMA 2020 guidelines, MEDLINE (PubMed) was searched for records from inception to December 2025. Eligible studies included original research involving human participants that utilised recognised AI techniques, such as convolutional neural networks (CNNs) or random forests, for patch testing or skin sensitisation assessment and reported quantifiable performance metrics.

Results

Eleven studies met the inclusion criteria from 123 records screened. Methodologies spanned automated image interpretation, molecular analysis, and sensitisation risk modelling. CNNs achieved high classification accuracy for patch test reactions, ranging from 90.1% to 99.5%. Molecular models discriminated allergic from irritant contact dermatitis with accuracies between 86% and 100%. Conversely, clinical risk prediction models showed moderate discrimination (mean AUC 0.69). Critical limitations included small, single-centre datasets, class imbalance, and inconsistent reporting of skin phototypes.

Conclusions

AI demonstrates credible technical capability in reaction detection and molecular discrimination but is currently constrained by dataset heterogeneity and a lack of external validation. Consequently, AI currently functions best as a decision-support system rather than an autonomous diagnostic tool.

Zitieren

APA

Al-tharwane, S., & *, M. S. A. A. (2026). Patch Testing in the Age of Artificial Intelligence (AI): Opportunities and Risks. Dermatology and Dermatitis, 13(01), 01-07. https://doi.org/10.31579/2578-8949/204

Vancouver

Al-tharwane S, * MSAA. Patch Testing in the Age of Artificial Intelligence (AI): Opportunities and Risks. Dermatology and Dermatitis. 2026;13(01):01-07. doi:10.31579/2578-8949/204

BibTeX
@article{Altharwane2026,
  author = {Al-tharwane, Shaymaa and *, Mohammed S Al Abadie},
  title = {Patch Testing in the Age of Artificial Intelligence (AI): Opportunities and Risks},
  journal = {Dermatology and Dermatitis},
  year = {2026},
  volume = {13},
  number = {01},
  pages = {01--07},
  doi = {10.31579/2578-8949/204}
}
Kostenlos starten →